相似文献
1
Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D.
World J Gastroenterol. 2011 Dec 7;17(45):4987-92. doi: 10.3748/wjg.v17.i45.4987.
2
3
Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil.
BMC Microbiol. 2008 Jan 22;8:11. doi: 10.1186/1471-2180-8-11.
4
Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
J Med Virol. 2007 Nov;79(11):1664-70. doi: 10.1002/jmv.20984.
5
Detection of HBV resistance to lamivudine in patients with chronic hepatitis B using Zip nucleic acid probes in Kerman, southeast of Iran.
Asian Pac J Cancer Prev. 2012;13(8):3657-61. doi: 10.7314/apjcp.2012.13.8.3657.
6
[YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy].
Mikrobiyol Bul. 2008 Jul;42(3):445-50.
7
Lamivudine resistance in untreated chronic hepatitis B patients in Turkey.
Turk J Gastroenterol. 2008 Jun;19(2):99-103.
8
[Determination of hepatitis B virus genotype and detection of lamivudine-resistance mutations].
Gastroenterol Hepatol. 2004 Nov;27(9):515-20. doi: 10.1016/s0210-5705(03)70518-4.
9
Long-term effects of lamivudine treatment in Japanese chronic hepatitis B patients.
World J Gastroenterol. 2011 Jun 28;17(24):2945-52. doi: 10.3748/wjg.v17.i24.2945.
10
Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine.
Int J Infect Dis. 2008 Jan;12(1):83-7. doi: 10.1016/j.ijid.2007.05.001. Epub 2007 Aug 14.
引用本文的文献
1
Review of the Effects of Antiviral Therapy on Hepatitis B/C-Related Mortality and the Regression of Fibrosis.
Viruses. 2024 Sep 27;16(10):1531. doi: 10.3390/v16101531.
2
Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions.
Viruses. 2021 Apr 28;13(5):777. doi: 10.3390/v13050777.
3
An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia.
J Gastroenterol. 2020 Sep;55(9):811-823. doi: 10.1007/s00535-020-01698-4. Epub 2020 Jul 14.
4
Relationship between hepatocellular carcinoma and hepatitis B virus genotype with spontaneous YMDD mutations.
World J Gastroenterol. 2013 Jun 28;19(24):3861-5. doi: 10.3748/wjg.v19.i24.3861.
5
Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.
World J Gastroenterol. 2012 Dec 28;18(48):7149-57. doi: 10.3748/wjg.v18.i48.7149.
本文引用的文献
1
Lamivudine resistance in untreated chronic hepatitis B patients in Turkey.
Turk J Gastroenterol. 2008 Jun;19(2):99-103.
2
EASL Clinical Practice Guidelines: management of chronic hepatitis B.
J Hepatol. 2009 Feb;50(2):227-42. doi: 10.1016/j.jhep.2008.10.001. Epub 2008 Oct 29.
3
YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.
J Gastroenterol Hepatol. 2006 Dec;21(12):1783-8. doi: 10.1111/j.1440-1746.2006.04567.x.
4
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update.
Clin Gastroenterol Hepatol. 2006 Aug;4(8):936-62. doi: 10.1016/j.cgh.2006.05.016. Epub 2006 Jul 14.
5
Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
Neth J Med. 2006 Jun;64(6):175-85.
6
The current management of HBV drug resistance.
J Clin Virol. 2005 Dec;34 Suppl 1:S143-6. doi: 10.1016/s1386-6532(05)80025-3.
7
Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico.
J Antimicrob Chemother. 2006 Feb;57(2):221-3. doi: 10.1093/jac/dki457. Epub 2005 Dec 22.
8
Character of HBV (hepatitis B virus) polymerase gene rtM204V/I and rtL180M mutation in patients with lamivudine resistance.
J Zhejiang Univ Sci B. 2005 Jul;6(7):664-7. doi: 10.1631/jzus.2005.B0664.
9
Molecular epidemiology of hepatitis B virus in Spain: identification of viral genotypes and prediction of antigenic subtypes by limited sequencing.
J Med Virol. 2005 Jun;76(2):176-84. doi: 10.1002/jmv.20341.
10
YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.
World J Gastroenterol. 2005 Feb 14;11(6):867-70. doi: 10.3748/wjg.v11.i6.867.
Zotero 插件